Malaria vaccine deployment in Africa: focus on Ghana

  • Kwaku Poku Asante Kintampo Health Research Centre, Kintampo, Ghana
  • Fred N. Binka School of Public Health, University of Health and Allied Sciences, Hohoe, Ghana
  • Kwadwo A. Koram Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana


The announcement by the Ghana Health Service /Ministry of Health at the beginning of May to begin the pilot implementation of the malaria vaccine – RTS,S/AS01 (Mosquirix®) – manufactured by GSK Biologicals was greeted with rumours about conspiracy theories of secret
agenda to depopulate Africa through the use of vaccines and all the other stories that are often propagated by the anti vaxxers. This was not unlike the fear and panic spread throughout the country that prevented investigators from conducting clinical trials on new vaccines against the Ebola virus disease a few years ago.


Journal Identifiers

print ISSN: 0016-9560